Analyst stock forecast
CRISPR Therapeutics AG - Common Shares Stock Forecast and Analyst Price Target
CRSP analyst target range, upside, consensus rating and coverage count.
Direct answer
CRISPR Therapeutics AG - Common Shares's average price target is $87.56.
The target implies +61.9% from the recorded current price, and the consensus rating is Buy.
The verified range is $44.00 to $291.00, with 18 analysts in the current consensus when available.
Forecast evidence checked August 12, 2026.
Get free CRISPR Therapeutics AG - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $54.07
- Average price target
- $87.56
- High price target
- $291.00
- Low price target
- $44.00
- Target upside
- +61.9%
- Consensus rating
- Buy
- Analysts
- 18
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026